Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Orthocell Ltd ( (AU:OCC) ) is now available.
Orthocell Ltd has announced the quotation of 230,770 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 14, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the visibility and accessibility of its securities.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company specializes in innovative treatments for repairing and regenerating soft tissue injuries and musculoskeletal conditions.
Average Trading Volume: 781,534
Technical Sentiment Signal: Buy
Current Market Cap: A$297.9M
Learn more about OCC stock on TipRanks’ Stock Analysis page.